Sunshine Biopharma Inc (SBFM)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Sunshine Biopharma Sets its Sight on New York City, Boasts Impressive Revenue Growth
Sunshine Biopharma Inc Surprises Experts with Jaw-Dropping 4385.926% Surge in Revenue
Sunshine Biopharma Inc Shines Bright with Remarkable Revenue Growth in Q1 2023
The company reported that Revenues have truly advanced, in the fiscal time-frame closing Sep 30 2022
The Losses have intensified more at SBFM in the April to June 30 2022 interval
Revenues were $0.085118 million at the SBFM in fiscal fourth quarter of 2021